Lymphoma Diagnosis and Plasma Epstein-Barr Virus Load during Vicriviroc Therapy: Results of the AIDS Clinical Trials Group A5211

BACKGROUND: Lack of functional CCR5 increases the severity of certain viral infections, including West Nile virus and tickborne encephalitis. In a phase II trial of the investigational CCR5 antagonist vicriviroc (AIDS Clinical Trials Group protocol A5211), 4 lymphomas occurred in study patients who...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tsibris, Athe M. N., Paredes, Roger, Chadburn, Amy, Su, Zhaohui, Henrich, Timothy J., Krambrink, Amy, Hughes, Michael D., Aberg, Judith A., Currier, Judith S., Tashima, Karen, Godfrey, Catherine, Greaves, Wayne, Flexner, Charles, Skolnik, Paul R., Wilkin, Timothy J., Gulick, Roy M., Kuritzkes, Daniel R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2756462/
https://ncbi.nlm.nih.gov/pubmed/19191652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/597007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados